Bal Pharma Ltd.
Snapshot View

89.80 +0.75 ▲0.8%

08 December 2022, 04:01:00 PM
Volume: 1,464

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.balpharma.com
Market Cap 140.58 Cr.
Enterprise Value(EV) 262.31 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.92 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 46.86 Trailing Twelve Months Ending 2022-09
Industry PE 34.64 Trailing Twelve Months Ending 2022-09
Book Value / Share 38.58 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.33 Calculated using Price: 89.80
Dividend Yield 1.12 Period Ending 2022-03
No. of Shares Subscribed 1.57 Cr. 15,689,872 Shares
FaceValue 10
Company Profile
Bal Pharma, incorporated in 1987 is engaged in the business interest in area of manufacturing API, finished formulations, ayurvedic and research and development. It is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.84%
1 Week
+2.86%
1 Month
-4.72%
3 Month
-7.61%
6 Month
-9.16%
1 Year
-9.70%
2 Year
+49.92%
5 Year
-5.87%
10 Year
+252.85%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 12.03 7.00 0.49 -0.69 0.59 3.27 -21.65 8.97 10.34
Return on Capital Employed (%) 14.05 10.88 7.35 7.59 7.45 6.88 -0.44 9.72 12.33
Return on Assets (%) 3.50 2.23 0.14 -0.18 0.15 0.83 -5.16 1.97 2.28

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 50 55 55 62 65 67 52 54 59 60
Non Curr. Liab. 18 16 45 30 46 38 34 34 36 42
Curr. Liab. 87 92 111 143 154 163 159 153 166 187
Minority Int. 0 0 -2 -5 -6 -7 0 0 0
Equity & Liab. 155 164 211 233 260 261 238 240 261 290
Non Curr. Assets 60 59 68 69 75 78 81 76 76 76
Curr. Assets 95 105 143 165 185 183 157 164 185 214
Misc. Exp. not W/O
Total Assets 155 164 211 233 260 261 238 240 261 290

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 179 187 198 229 209 225 171 251 281 288
Other Income 1 1 1 3 2 1 2 1 5 5
Total Income 180 188 200 232 211 226 173 252 286 293
Total Expenditure -161 -170 -183 -214 -192 -207 -166 -226 -257 -268
PBIDT 19 18 16 18 19 19 7 26 29 25
Interest -7 -7 -6 -8 -9 -13 -13 -12 -11 -10
Depreciation -5 -7 -7 -6 -7 -6 -8 -10 -9 -9
Taxation -2 -1 -2 -3 -3 2 1 1 -3 -3
Exceptional Items
PAT 5 4 0 0 0 2 -13 5 6 3
Minority Interest 0 1 2 2 2 1 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 5 4 1 2 3 4 -12 5 6 3
Adjusted EPS 5 3 1 1 2 3 -9 3 4 2

Cash Flow View Details >>

Particulars 10 years 2011-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 5 13 15 -19 6 1 8 23 22 28
Cash Fr. Inv. -2 -7 -5 -14 -8 -4 -8 -5 -6 -9
Cash Fr. Finan. -2 -8 -7 32 -6 4 0 -20 -17 -18
Net Change 1 -2 2 -1 -8 1 0 -1 0 0
Cash & Cash Eqvt 2 3 5 5 -25 3 2 1 1 1

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 42.45 42.45 44.98 44.84 46.87 49.57 49.57 52.00 52.00
Public 57.55 57.55 55.02 55.16 53.13 50.43 50.43 48.00 48.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 02 Dec 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
We are submitting to the exchanges the advertisement published in Financial Express (English Version) and in Sanjayvani (Kannada Version) on 1st December 2022 regarding the public notice issued for transfer of shares of the Company to the IEPF account.
Mon, 28 Nov 2022
Disclosure Of Related Party Transactions
We are submitting to the exchanges statement of the related party transactions of the Com[pany for the half year ended 30.09.2022.
Thu, 24 Nov 2022
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
The Company has received the letter of resignation from Mr.G.Rengarajan CFO of the Company citing health issues and personal commitments. Mr.G.Rengarajan ceases to be the CFO of the Company from the closure of business hours on 24.11.2022.

Technical Scans View Details >>

Thu, 08 Dec 2022
High Delivery Percentage High Delivery Percentage
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
5 SMA Crossing 20 SMA From Below 5 SMA Crossing 20 SMA From Below
Close Crossing 20 EMA From Below Close Crossing 20 EMA From Below
Wed, 07 Dec 2022
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,362.76 980.95 -3.6%
Cipla Ltd. 89,585.15 1,110.00 +0.4%
Divi's Laboratories Ltd. 87,333.85 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. 72,223.59 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. 67,735.51 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. 54,831.55 1,620.10 -0.4%
Abbott India Ltd. 43,044.71 20,257.00 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 57.34 980.95 -3.6%
Cipla Ltd. Consolidated 2022-09 34.91 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 29.18 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.23 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.68 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.80 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-09 48.82 20,257.00 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.43 980.95 -3.6%
Cipla Ltd. Consolidated 2022-09 4.09 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 7.20 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.48 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.32 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.00 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-09 15.86 20,257.00 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 0.00 20,257.00 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,257.00 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,257.00 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,257.00 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 798.70 20,257.00 +0.2%

FAQ's On Bal Pharma Ltd.

What is Bal Pharma share price?

Can I buy Bal Pharma shares now?

What is the Dividend Yield of Bal Pharma?

What is the Market Cap of Bal Pharma?

What are the key metrics to analyse Bal Pharma?

What is the 52 Week High and Low of Bal Pharma?

What is the trend of Bal Pharma share price?